AlleCures is a spinout of Colby Pharmaceuticals. The AlleCures™ platform is based on years of international clinical studies and research. We are committed to creating safe treatment for allergies and developing innovative solutions for medical professionals.
Immunotherapies for Allergic Disease Control
Trials & Investing
We have patented technologies, with extensive clinical trials, that show how IntraLymphNode Allergen ImmunoTherapy (IL-AIT) can eliminate allergy symptoms for years.
We are currently raising funds to launch the AlleCures™ platform in the USA. We will be looking to expand our US clinical trials for specific allergens. These include food based allergens like peanut and shellfish. We believe the AlleCure™ Platform could eliminate sensitivity to these allergens.